SynthesisBMC nephrology2024

Economic evaluation of adding dapagliflozin to standard care in the treatment of chronic kidney disease: a systematic review.

Lu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.